Marsh & Mclennan Plunges 4.9% Amid Executive Trading, Underperform Rating

On April 10, 2025, Marsh & Mclennan's stock experienced a significant drop of 4.9% in pre-market trading, reflecting a notable decline in investor sentiment.

Keefe, Bruyette & Woods recently maintained an underperform rating for Marsh & Mclennan, setting a target price of $220.00. This decision comes after the company reported its 2024 annual results, which showed a 7.57% increase in revenue to $244.58 billion and a net profit of $41.17 billion, with earnings per share at $8.26.

Recent internal trading activities at Marsh & Mclennan have also drawn attention. High-level executives, including Paul Beswick and Dean Michael Klisura, have been involved in significant stock transactions. Beswick sold 2,237 shares at $246.00 each, while Klisura bought and sold 9,569 shares at varying prices. These transactions suggest a mixed outlook among the company's leadership, which could influence market perceptions and stock performance.